A phase i study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

Steven J. Cohen, Mark M. Zalupski, Manuel R. Modiano, Paul Conkling, Yehuda Z. Patt, Peg Davis, Robert T. Dorr, Michelle L. Boytim, Evan M. Hersh

Research output: Contribution to journalArticle

19 Scopus citations

Fingerprint Dive into the research topics of 'A phase i study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds